Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
life sciences
national blog main
4
×
boston top stories
clinical trials
deals
fda
investing
san francisco blog main
startups
480 biomedical
akouos
arsenal medical
astellas pharmaceuticals
azacitidine
beta-thalassemia
biotech ipos
bob langer
california institute for biomedical research
chronic rhinosinusitis
covid-19
dacogen
decibel therapeutics
decitabine
dna
drug delivery
dyne therapeutics
epigenetics
epizyme
farydak
flagship pioneering
frequency therapeutics
fulcrum therapeutics
genzyme
george whitesides
harvard university
hearing loss
inflammation
What
developing
4
×
therapeutics
ipo
medicines
biotech
company
drug
million
new
raised
treat
affects
aims
americans
approach
approved
based
brings
called
date
debut
debuts
disorders
drugs
dyne
dyne’s
epigenetic
epigenetics
fda
field
flagship’s
frequency
genetic
hearing
late
loss
lyra
markets
meds
millions
Language
unset
4
×
Current search:
unset
×
developing
×
boston
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds